See a Demo

Tag: Lay Summaries

TrialAssure cubes divider
Clinical Trial Information System (CTIS) Medical Writing AI Generative Text

TrialAssure Announces AI Generative Text Partnership with Top Clinical Research Organization MMS on New Medical Writing Initiative

by Don McLean | August 2023

Posted in Blog, News
Read More
Revolutionizing Clinical Trial Transparency trialassure results disclosure registration anonymization redaction plain language summaries lay summaries TrialAssure® is a global, award-winning clinical trial and human health data transparency software suite. TrialAssure helps meet regulatory compliance goals through a flexible, scalable, and streamlined software-as-a-service (SaaS) platform that supports risk-based dataset and document anonymization, data-driven plain language summaries, and clinical trial registry activities.

New TrialAssure LINK Technology Saves Up to 4 Weeks from Plain Language Summary Writing

by Staff Writer | June 2021

Posted in News
Read More
trialassure data sharing EMA COVID-19 assessments Clinical Trials Information System (CTIS), a new European trial registry due CTIS EU Clinical Trial Regulation

Whitepaper: Start Plain Language Summaries Early or Get Left Behind

by Staff Writer | December 2020

Posted in Blog
Read More
The U.S. Senate had voted in favor of an opioid bill that expands Open Payments to include payments made to Nurse Practitioners, Physician Assistants, Nurse Midwifes, Nurse Anesthetists, and Clinical Nurse Specialists, in addition to current physician reporting requirements. This will go into effect beginning January 1, 2022. Inconsistent Clinical Trial Disclosure and Lack of Compliance Across Big Pharma

This week in transparency news: June 8 – June 14, 2019

by Staff Writer | June 2019

Posted in Blog
Read More
Outsourcing-Pharma released a State of the Industry report that sheds light on the global pharmaceutical industry. One of the key findings in the report showed that more than half of survey respondents believe that industry initiatives will lead to greater transparency. The report points to a new pilot program launched earlier this year by the FDA to increase transparency. Clinical Trial Transparency Software client feedback

This week in transparency news: June 1 – June 7, 2019

by Staff Writer | June 2019

Posted in Blog
Read More
Should people share their DNA for drug development purposes? – USA Today Many people don’t realize that sharing a DNA sample with Ancestry.com, 23andMe and others can result in their data being shared. However, this week, the companies pledged that they would disclose when data is shared with corporations or the government. With a $300 million investment by GSK in 23andMe, they state that approximately 80 percent of customers have agreed to share their DNA data. This data is being de-identified before it is shared.

This week in transparency news: May 18 – May 24, 2019

by Staff Writer | May 2019

Posted in Blog
Read More
bioethics international good pharma scorecard gps disclosure clinical trial transparency trialassure

This week in transparency news: July 7 – July 13, 2018

by Staff Writer | July 2018

Posted in Blog
Read More
Get in Touch

Looking to streamline your clinical trial disclosure and transparency efforts?

TrialAssure is ready to help your organization embark on a Transparency Transformation!

To learn more about the TrialAssure Transparency Suite, specific products, or our company, contact us below.

Yes, please send me more information about TrialAssure.

  • *